Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.
Hypertension, a multifactorial-polygenic disease, interacts with multiple environmental stressors and results in functional and structural changes in numerous end organs, including the cardiovascular system. This can result in coronary heart disease, stroke, peripheral vascular disease, congestive heart failure, end-stage renal disease, insulin resistance, and damage to the pancreatic islet. Hypertension is the most important modifiable risk factor for major health problems encountered in clinical practice. Whereas hypertension was once thought to be a medical condition based on discrete blood pressure readings, a new concept has emerged defining hypertension as part of a complex and progressive metabolic and cardiovascular disease, an important part of a cardiometabolic syndrome. The central role of insulin resistance, oxidative stress, endothelial dysfunction, metabolic signaling defects within tissues, and the role of enhanced tissue renin-angiotensin-aldosterone system activity as it relates to hypertension and type 2 diabetes mellitus are emphasized. Additionally, this review focuses on the effect of hypertension on functional and structural changes associated with the vulnerable pancreatic islet. Various classes of antihypertensive drugs are reviewed, especially their roles in delaying or preventing damage to the vulnerable pancreatic islet, and thus delaying the development of type 2 diabetes mellitus.
Hayden
Melvin R
MR
Departments of Internal Medicine, Endocrinology Diabetes and Metabolism, and Diabetes and Cardiovascular Disease Research Center, School of Medicine, University of Missouri-Columbia, Health Sciences Center, Columbia, Missouri, USA.
Sowers
James R
JR
Hypertension. 1994 Jan;23(1):44-51
8282330
Am J Hypertens. 1996 Nov;9(11):150S-154S
8931847
Hypertens Res. 2003 May;26(5):383-7
12887129
J Hypertens. 2000 Nov;18(11):1611-20
11081774
Metabolism. 1999 Oct;48(10):1248-55
10535386
Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47
16487914
J Hypertens. 2002 Jul;20(7):1413-21
12131539
Diabetes Care. 2004 Jan;27(1):247-55
14693997
Am J Physiol. 1996 Feb;270(2 Pt 2):F289-94
8779889
Diabetes. 1983 Feb;32(2):106-11
6337892
N Engl J Med. 2006 Oct 12;355(15):1551-62
16980380
Diabetes Care. 2006 Dec;29(12):2592-7
17130190
Metabolism. 2006 Sep;55(9):1159-64
16919533
Am J Cardiovasc Drugs. 2006;6(3):139-47
16780387
JOP. 2001 Jul;2(4):124-39
11875249
Chem Biol. 2000 Jul;7(7):493-504
10903938
Am J Hypertens. 2001 Sep;14(9 Pt 1):921-6
11587159
J Hypertens. 2001 Jan;19(1):113-8
11204290
BMJ. 1994 Jul 23;309(6949):226-30
7818648
Pharmacology. 2006;76(1):8-18
16220025
Antioxid Redox Signal. 2007 Jul;9(7):891-910
17516840
Diabetes. 2004 Apr;53(4):989-97
15047614
Lancet. 1999 Feb 20;353(9153):611-6
10030325
Lancet. 2007 Jan 20;369(9557):201-7
17240286
Hypertension. 2006 Oct;48(4):677-84
16940222
Mayo Clin Proc. 2006 Jun;81(6):796-806
16770980
Am Heart J. 2005 Sep;150(3):426-33
16169319
N Engl J Med. 2003 Apr 3;348(14):1309-21
12668699
Lancet. 2007 Jul 21;370(9583):221-229
17658393
J Cardiometab Syndr. 2007 Winter;2(1):70-5
17684452
Am J Cardiovasc Drugs. 2005;5(1):17-22
15631534
Diabetologia. 1998 Feb;41(2):127-33
9498644
Acta Physiol Scand. 1996 Sep;158(1):29-37
8876745
Curr Opin Nephrol Hypertens. 2004 May;13(3):325-32
15073492
Diabetes Care. 1993 Feb;16(2):434-44
8432214
Drugs. 2004;64(17):1923-40
15329044
QJM. 2006 Jul;99(7):431-6
16766516
Diabetes Care. 2005 Sep;28(9):2261-6
16123505
Am J Hypertens. 1995 Jan;8(1):48-52
7734096
Hypertension. 2002 Nov;40(5):679-86
12411462
Clin Chim Acta. 2006 Feb;364(1-2):328-34
16150432
Eur J Endocrinol. 2006 Feb;154(2):355-61
16452552
Hypertension. 1997 Nov;30(5):1156-61
9369270
Arch Intern Med. 2006 Nov 13;166(20):2191-201
17101936
Circulation. 1998 Dec 1;98(22):2453-60
9832492
Lancet. 2006 Nov 11;368(9548):1673-9
17098085
Am J Med. 1996 Sep 30;101(3A):33S-46S
8876473
J Am Soc Nephrol. 2005 Mar;16(3):592-9
15703270
Curr Hypertens Rep. 2000 Oct;2(5):451-6
10995520
N Engl J Med. 1999 Sep 2;341(10):709-17
10471456
J Cell Physiol. 2003 Jul;196(1):171-9
12767053
Diabetes Care. 2003 Mar;26(3):688-96
12610023
Blood Press. 1992 Aug;1(2):92-101
1366265
J Hypertens. 2005 Oct;23(10):1777-81
16148594
Circulation. 2005 Dec 13;112(24):3795-801
16330685
N Engl J Med. 2000 Mar 30;342(13):969-70
10738057
Am Heart J. 2004 Jul;148(1):52-61
15215792
Lancet. 2003 Sep 6;362(9386):759-66
13678868
Metabolism. 2006 Sep;55(9):1149-54
16919531
J Cardiometab Syndr. 2006 Winter;1(1):36-40
17675901
J Hypertens. 2003 Aug;21(8):1563-74
12872052
Diabetes. 2003 Nov;52(11):2759-66
14578294
Eur J Pharmacol. 2006 Jan 4;529(1-3):55-62
16313901
J Hypertens Suppl. 1993 Apr;11(3):S49-52
8315520
BMJ. 1989 Apr 29;298(6681):1152-7
2500169
Diabetologia. 2004 Sep;47(9):1519-27
15322749
J Physiol. 2003 Sep 1;551(Pt 2):673-82
12815182
N Engl J Med. 1996 Jan 4;334(1):13-8
7494564
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Am J Cardiol. 2003 Jun 19;91(12A):30H-37H
12818733
Am J Hypertens. 1996 Apr;9(4 Pt 1):323-33
8722435
Hypertension. 2005 Oct;46(4):943-7
16087785
J Am Coll Cardiol. 2005 Sep 6;46(5):821-6
16139131
Diabetes Care. 1991 Mar;14(3):203-9
1828417
J Hypertens. 2007 Jan;25(1):217-26
17143194
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
Hypertension. 2002 Jan;39(1):E1-8
11799102
Eur J Endocrinol. 2006 Aug;155(2):293-6
16868143
Curr Hypertens Rep. 2007 Apr;9(2):106-11
17442220
Clin Exp Hypertens. 2006 Feb;28(2):181-8
16546843
Hypertension. 1994 Jan;23(1 Suppl):I12-5
8282343
Am J Physiol. 1998 Jun;274(6):R1777-82
9841487
N Engl J Med. 1993 Apr 1;328(13):914-21
8446138
Am J Cardiol. 2002 Jan 24;89(2A):18A-25A; discussion 25A-26A
11835907
Lancet. 2005 Sep 10-16;366(9489):895-906
16154016
Br J Gen Pract. 2005 Jun;55(515):437-43
15970067
Cardiovasc Drug Rev. 2004 Fall;22(3):155-68
15492765
J Clin Endocrinol Metab. 2001 Feb;86(2):713-8
11158035
Proc Nutr Soc. 2005 Aug;64(3):371-7
16048671
Clin Cornerstone. 2003;Suppl 4:S13-20
14986904
Am J Physiol. 1998 Dec;275(6):E1016-22
9843744
Diabetes. 2005 Dec;54(12):3442-52
16306360
Metabolism. 2005 Jan;54(1):132-8
15562391
JOP. 2002 Jul;3(4):86-108
12110767
J Appl Physiol (1985). 2001 Aug;91(2):687-92
11457782
J Hypertens. 2004 Oct;22(10):1977-82
15361770
Lancet. 2005 Sep 10-16;366(9489):907-13
16154017
Antioxid Redox Signal. 2007 Jul;9(7):865-7
17477794
Exp Biol Med (Maywood). 2007 Jun;232(6):772-9
17526769
J Hypertens. 2005 Mar;23(3):589-96
15716701
Diabetes. 2003 Sep;52(9):2304-14
12941770
J Renin Angiotensin Aldosterone Syst. 2003 Mar;4(1):6-10
12692747
J Hypertens. 2005 Feb;23(2):417-26
15662231
J Cardiovasc Pharmacol. 2006 Jan;47(1):117-22
16424795
JAMA. 2003 May 21;289(19):2560-72
12748199
Curr Hypertens Rep. 2007 Apr;9(2):98-105
17442219
Am J Hypertens. 2005 Aug;18(8):1130-2
16109329
J Cardiometab Syndr. 2006 Winter;1(1):16-24
17675904
Circulation. 2005 Mar 1;111(8):1012-8
15723979
J Clin Hypertens (Greenwich). 2006 Aug;8(8):546-8
16896269
Br Med J. 1979 Jan 20;1(6157):159-61
369646
J Hum Hypertens. 2005 Jun;19 Suppl 1:S15-20
16075028
J Hum Hypertens. 2007 Oct;21(10):780-7
17541390
Hypertension. 2004 May;43(5):993-1002
15007034
Blood Press. 2005;14(1):6-11
15823941
Am J Physiol. 1999 Jul;277(1):R332-6
10409290
Hypertension. 2007 May;49(5):1047-55
17353513
Arch Intern Med. 1998 Apr 13;158(7):741-51
9554680
N Engl J Med. 1996 Feb 8;334(6):374-81
8538710
N Engl J Med. 2000 Mar 30;342(13):905-12
10738048
Diabetes. 2005 Jan;54(1):8-14
15616005
Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1597-602
15072967
Hypertension. 2006 Sep;48(3):385-91
16864741
Am J Hypertens. 1998 Oct;11(10):1258-65
9799045
Coron Artery Dis. 2005 Feb;16(1):67-73
15654203
J Clin Hypertens (Greenwich). 2004 Aug;6(8):425-7
15308879
Nat Rev Drug Discov. 2002 Aug;1(8):621-36
12402502
J Hypertens. 1991 Mar;9(3):225-30
1851785
JOP. 2001 Jan;2(1):26-32
11862019
Hypertension. 2004 May;43(5):1003-10
15037562
Pharmacol Ther. 2003 Dec;100(3):215-34
14652111
Am J Hypertens. 2005 Nov;18(11):1496-502
16280288
Hypertension. 2004 May;43(5):963-9
15037557
J Appl Physiol (1985). 1999 Jun;86(6):2044-51
10368372
J Hypertens. 2005 Apr;23(4):891-8
15775796
Circulation. 2003 Mar 11;107(9):1291-6
12628950
Hypertens Res. 2005 Feb;28(2):107-12
16025736
Hypertens Res. 2004 Apr;27(4):293-9
15127887
Biochem Biophys Res Commun. 2006 Jul 21;346(1):26-32
16756954
J Clin Endocrinol Metab. 2006 Feb;91(2):454-9
16291704
Cardiovasc Diabetol. 2005 Jan 04;4:1
15631632
J Clin Endocrinol Metab. 1972 Jan;34(1):235-40
4550329
N Engl J Med. 2000 Jan 20;342(3):145-53
10639539
N Engl J Med. 2004 Nov 11;351(20):2058-68
15531767
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2376-80
16179595
JAMA. 2001 May 16;285(19):2486-97
11368702
J Hum Hypertens. 2006 Jan;20(1):37-43
16121197
J Hypertens. 2006 Mar;24(3):591-6
16467663
Endocrinology. 2007 Aug;148(8):3773-80
17494996
Clin Appl Thromb Hemost. 2005 Apr;11(2):139-46
15821820
Am J Hypertens. 2000 Mar;13(3):290-7
10777034
J Hypertens. 2001 Aug;19(8):1429-35
11518851
Am Heart J. 1983 Jul;106(1 Pt 2):245-51
6869206
Bioorg Med Chem. 2006 Jul 1;14(13):4568-77
16510286
Lancet. 2003 Sep 6;362(9386):777-81
13678871
Br J Nutr. 2000 Mar;83 Suppl 1:S39-48
10889791
Biochem Biophys Res Commun. 2003 Sep 5;308(4):698-705
12927775
Hypertension. 2001 Feb;37(2 Pt 2):433-9
11230314
Hypertension. 1995 Sep;26(3):460-4
7649582
JAMA. 2003 Dec 3;290(21):2805-16
14657064
Diabetes. 1983 Jan;32(1):35-45
6336701
Am J Ther. 2006 Jan-Feb;13(1):2-7
16428915
Arch Intern Med. 1992 Aug;152(8):1649-51
1386725
Diabetologia. 2004 Feb;47(2):240-8
14722647
J Hum Hypertens. 1994 Apr;8(4):257-63
7912734
Diabetes Care. 2006 May;29(5):1065-70
16644638
J Am Coll Cardiol. 2007 Mar 20;49(11):1157-63
17367658
Acta Physiol Scand. 2004 Aug;181(4):571-7
15283772
Int J Biochem Cell Biol. 2003 Jun;35(6):838-46
12676170
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8628-32
3317417
Am J Hypertens. 2002 Nov;15(11):927-31
12441210
JOP. 2005 Jul 08;6(4):287-302
16006679
JAMA. 2000 Apr 19;283(15):1967-75
10789664
Ann Behav Med. 1997 Summer;19(3):239-63
9603699
Hypertension. 2005 Jul;46(1):137-43
15939809
Diabetes. 2002 Jun;51(6):1699-707
12031955
J Hypertens. 2002 Sep;20(9):1879-86
12195132
Hypertension. 2003 Dec;42(6):1137-43
14597641
Arch Intern Med. 2006 Apr 10;166(7):797-805
16606818
Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S33-5
11126238
Circulation. 2004 May 4;109(17):2054-7
15117841
Circulation. 2005 Jul 5;112(1):48-53
15983242
Endocrinology. 2002 Feb;143(2):339-42
11796484
Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E353-9
15494608
Obes Res. 2002 Oct;10(10):1087-91
12376591
JOP. 2007 Nov 09;8(6):725-38
17993725
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):53-8
15134801
J Clin Invest. 1996 May 1;97(9):2111-8
8621801
Hypertension. 2001 Sep;38(3 Pt 2):705-8
11566961
J Mol Endocrinol. 2001 Jun;26(3):155-64
11432370